Abstract:Periodontitis can result in tooth loss and the associated chronic inflammation can provoke several severe systemic health risks. Adjunctive to mechanical treatment of periodontitis and as alternatives to antibiotics, the use of probiotic bacteria was suggested. In this study, the inhibitory effect of the probiotic Streptococcus salivarius subsp. salivarius strains M18 and K12, Streptococcus oralis subsp. dentisani 7746, and Lactobacillus reuteri ATCC PTA 5289 on anaerobic periodontal bacteria and Aggregatibacter actinomycetemcomitans was tested. Rarely included in other studies, we also quantified the inverse effect of pathogens on probiotic growth. Probiotics and periodontal pathogens were co-incubated anaerobically in a mixture of autoclaved saliva and brain heart infusion broth. The resulting genome numbers of the pathogens and of the probiotics were measured by quantitative real-time PCR. Mixtures of the streptococcal probiotics were also used to determine their synergistic, additive, or antagonistic effects. The overall best inhibitor of the periodontal pathogens was L . reuteri ATCC PTA 5289, but the effect is coenzyme B12-, anaerobiosis-, as well as glycerol-dependent, and further modulated by L . reuteri strain DSM 17938. Notably, in absence of glycerol, the pathogen-inhibitory effect could even turn into a growth spurt. Among the streptococci tested, S . salivarius M18 had the most constant inhibitory potential against all pathogens, followed by K12 and S . dentisani 7746, with the latter still having significant inhibitory effects on P . intermedia and A . actinomycetemcomitans . Overall, mixtures of the streptococcal probiotics did inhibit the growth of the pathogens equally or–in the case of A . actinomycetemcomitans - better than the individual strains. P . gingivalis and F . nucleatum were best inhibited by pure cultures of S . salivarius K12 or S . salivarius M18, respectively. Testing inverse effects, the growth of S . salivarius M18 was enhanced when incubated with the periodontal pathogens minus/plus other probiotics. In contrast, S . oralis subsp. dentisani 7746 was not much influenced by the pathogens. Instead, it was significantly inhibited by the presence of other streptococcal probiotics. In conclusion, despite some natural limits such as persistence, the full potential for probiotic treatment is by far not utilized yet. Especially, further exploring concerted activity by combining synergistic strains, together with the application of oral prebiotics and essential supplements and conditions, is mandatory.

Exploring the In Vitro Antibacterial Potential of Specific Probiotic Strains against Oral Pathogens

In Vitro Selection of Lactobacillus and Bifidobacterium Probiotic Strains for the Management of Oral Pathobiont Infections Associated to Systemic Diseases

Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms

Investigating the antimicrobial and anti-inflammatory effects of Lactobacillus and Bifidobacterium spp. on cariogenic and periodontitis pathogens

Selection of Beneficial Bacterial Strains With Potential as Oral Probiotic Candidates

Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics

Topic Application of the Probiotic Streptococcus dentisani Improves Clinical and Microbiological Parameters Associated With Oral Health

Antibacterial activity of viable and heat‐killed probiotic strains against oral pathogens

A concerted probiotic activity to inhibit periodontitis-associated bacteria

In Vitro Antimicrobial Activity and Aggregation Abilities of Probiotic Lactobacillus casei and Lactobacillus salivarius Against Oral Pathogens

Interactions between probiotic and oral pathogenic strains

Oral Biofilm Composition, Dissemination to Keratinocytes, and Inflammatory Attenuation Depend on Probiotic and Synbiotic Strain Specificity

Probiotic Potential of Lactic Acid Bacterial Strains Isolated from Human Oral Microbiome

Probiotic Effect of Streptococcus dentisani on Oral Pathogens: An In Vitro Study

The immunomodulating role of probiotics in the prevention and treatment of oral diseases

Multi-function screening of probiotics to improve oral health and evaluating their efficacy in a rat periodontitis model

In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501(®) , Lactobacillus paracasei IMC 502(®) and SYNBIO(®) against pathogens

In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids

Probiotic candidates among dairy Lactobacilli and Streptococcus thermophiles strains for control of the oral pathogen Porphyromonas gingivalis

Polyphenols and Lactobacillus reuteri in oral health

Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases